Study period 1/1/2017 to 7/1/2025 Study population: inclusion Patients with A GLP-1 prescription for at least 90 days At least five pounds of weight loss while on the GLP-1 A weight reading between 30 days prior through 3 days after starting the GLP-1 A weight reading within 30 days of stopping the GLP-1 At least one weight reading 1 to 24 months following end of the GLP-1 Study population: exclusion Thyroid conditions (ever): ICD-10-CM E03*or E05* Eating disorders (ever): ICD-10-CM F50* Pregnancy within a year before GLP-1 start through GLP-1 stop Censoring Other weight loss medication or restart of GLP-1 Amputation Bariatric surgery Pregnancy that started in period after GLP-1 was stopped Outcomes Percent of weight change relative to initial weight loss after end of GLP-1 treatment GLP-1 A medication with a simple generic of semaglutide, liraglutide, or tirzepatide

Its worth noting that most side effects are gastro-intestinal related and most do subside with time, but if you find that you arent able to tolerate the side effects, you should make an appointment to talk with your prescriber about what steps you should take
Combined with nutrition and movement, it can support steady, sustainable weight loss with personalized care from our Drip Specialists
VFinal volume of the sample solution, in milliliters (mL)
PI3K/Akt is the commonest downstream signal pathway activated by GLP-1 receptor and has been shown to be activated by Ex-4 in animal models of stroke
L., Chapman, J., & Glanz, K